Over 20 years of experience in embryonic/induced pluripotent stem cells, cell therapy and gene editing.

Principal Investigator & Professor at Shanghai Institute of Biochemistry & Cell Biology and at Zhejiang University.

Postdoctorate at Johns Hopkins.

Ph.D. from Munich University, Germany.

US based.

Larry Lei Xiao, Ph.D

Co-Founder,
Chairman, CEO & CSO